Lori Anne Kunkel - 08 Dec 2025 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role: Director
Signature: /s/ Christian Kuhlen, attorney-in-fact
Issuer symbol: ORIC
Transactions as of: 08 Dec 2025
Net transactions value: +$79,000
Form type: 4
Filing time: 09 Dec 2025, 17:35:02 UTC
Previous filing: 05 Dec 2025
Next filing: 19 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kunkel Lori Anne	Director	C/O ORIC PHARMACEUTICALS, INC., 240 EAST GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO	/s/ Christian Kuhlen, attorney-in-fact	09 Dec 2025	0001536368

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORIC	Common Stock	Options Exercise	$79,000	+10,000	+13%	$7.90	84,200	08 Dec 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ORIC	Stock Option (right to buy)	Options Exercise	$0	-10,000	-39%	$0.000000	15,600	08 Dec 2025	Common Stock	10,000	$7.90	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2025 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.